Betta Pharmaceuticals Co., Ltd.

XSEC:300558 Stock Report

Market Cap: CN¥21.6b

Betta Pharmaceuticals Future Growth

Future criteria checks 4/6

Betta Pharmaceuticals is forecast to grow earnings and revenue by 26.7% and 18.6% per annum respectively. EPS is expected to grow by 28.9% per annum. Return on equity is forecast to be 11% in 3 years.

Key information

26.7%

Earnings growth rate

28.9%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate18.6%
Future return on equity11.0%
Analyst coverage

Low

Last updated21 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300558 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,5328501,9081,3635
12/31/20253,7416531,5251,3145
12/31/20243,1375341,0291,2522
9/30/20242,7574603111,186N/A
6/30/20242,6434241641,076N/A
3/31/20242,660395-801,023N/A
12/31/20232,456348-182914N/A
9/30/20232,757347-304657N/A
6/30/20232,437199-588539N/A
3/31/20232,324113-623415N/A
12/31/20222,377145-704307N/A
9/30/20222,184139-797276N/A
6/30/20222,344263-530426N/A
3/31/20222,212319-373478N/A
1/1/20222,246383-232527N/A
9/30/20212,087439-95616N/A
6/30/20212,074678-227521N/A
3/31/20211,842624-317439N/A
12/31/20201,870606-40646N/A
9/30/20201,818546-22656N/A
6/30/20201,744287150671N/A
3/31/20201,826310220739N/A
12/31/20191,554231-65555N/A
9/30/20191,540218-178448N/A
6/30/20191,405187-291375N/A
3/31/20191,314176-368314N/A
12/31/20181,224167-328286N/A
9/30/20181,186202-322313N/A
6/30/20181,110187N/A316N/A
3/31/20181,081225N/A282N/A
12/31/20171,026258N/A278N/A
9/30/20171,016264N/A276N/A
6/30/20171,015294N/A302N/A
3/31/2017990341N/A355N/A
12/31/20161,035369N/A407N/A
9/30/2016987364N/A400N/A
12/31/2015915345N/A386N/A
12/31/2014704271N/A278N/A
12/31/2013481180N/A190N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300558's forecast earnings growth (26.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 300558's earnings (26.7% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 300558's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300558's revenue (18.6% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300558's revenue (18.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300558's Return on Equity is forecast to be low in 3 years time (11%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y